Apellis Pharmaceuticals Stock Forecast - 8 Period Moving Average
| APLS Stock | USD 21.75 0.25 1.14% |
The 8 Period Moving Average forecasted value of Apellis Pharmaceuticals on the next trading day is expected to be 20.96 with a mean absolute deviation of 1.29 and the sum of the absolute errors of 69.40. Apellis Stock Forecast is based on your current time horizon.
At this time the rsi of Apellis Pharmaceuticals' share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.31) | EPS Estimate Current Year 0.265 | EPS Estimate Next Year (1.30) | Wall Street Target Price 34.5 | EPS Estimate Current Quarter 0.9418 |
Using Apellis Pharmaceuticals hype-based prediction, you can estimate the value of Apellis Pharmaceuticals from the perspective of Apellis Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Apellis Pharmaceuticals using Apellis Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Apellis using crowd psychology based on the activity and movement of Apellis Pharmaceuticals' stock price.
Apellis Pharmaceuticals Short Interest
An investor who is long Apellis Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Apellis Pharmaceuticals and may potentially protect profits, hedge Apellis Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 21.8858 | Short Percent 0.1677 | Short Ratio 7.18 | Shares Short Prior Month 17.2 M | 50 Day MA 22.7209 |
Apellis Pharmaceuticals Hype to Price Pattern
Investor biases related to Apellis Pharmaceuticals' public news can be used to forecast risks associated with an investment in Apellis. The trend in average sentiment can be used to explain how an investor holding Apellis can time the market purely based on public headlines and social activities around Apellis Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Apellis Pharmaceuticals Implied Volatility | 0.9 |
Apellis Pharmaceuticals' implied volatility exposes the market's sentiment of Apellis Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Apellis Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Apellis Pharmaceuticals stock will not fluctuate a lot when Apellis Pharmaceuticals' options are near their expiration.
The 8 Period Moving Average forecasted value of Apellis Pharmaceuticals on the next trading day is expected to be 20.96 with a mean absolute deviation of 1.29 and the sum of the absolute errors of 69.40. Apellis Pharmaceuticals after-hype prediction price | USD 21.75 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Apellis Pharmaceuticals to cross-verify your projections. Prediction based on Rule 16 of the current Apellis contract
Based on the Rule 16, the options market is currently suggesting that Apellis Pharmaceuticals will have an average daily up or down price movement of about 0.0563% per day over the life of the 2026-04-17 option contract. With Apellis Pharmaceuticals trading at USD 21.75, that is roughly USD 0.0122 . If you think that the market is fully incorporating Apellis Pharmaceuticals' daily price movement you should consider acquiring Apellis Pharmaceuticals options at the current volatility level of 0.9%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Apellis Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Apellis Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Apellis Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Apellis Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Apellis Pharmaceuticals' open interest, investors have to compare it to Apellis Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Apellis Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Apellis. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Apellis Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Apellis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Apellis using various technical indicators. When you analyze Apellis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Apellis Pharmaceuticals 8 Period Moving Average Price Forecast For the 25th of January
Given 90 days horizon, the 8 Period Moving Average forecasted value of Apellis Pharmaceuticals on the next trading day is expected to be 20.96 with a mean absolute deviation of 1.29, mean absolute percentage error of 3.20, and the sum of the absolute errors of 69.40.Please note that although there have been many attempts to predict Apellis Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Apellis Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Apellis Pharmaceuticals Stock Forecast Pattern
| Backtest Apellis Pharmaceuticals | Apellis Pharmaceuticals Price Prediction | Buy or Sell Advice |
Apellis Pharmaceuticals Forecasted Value
In the context of forecasting Apellis Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Apellis Pharmaceuticals' downside and upside margins for the forecasting period are 15.60 and 26.33, respectively. We have considered Apellis Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Apellis Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Apellis Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 106.4083 |
| Bias | Arithmetic mean of the errors | 0.0723 |
| MAD | Mean absolute deviation | 1.2852 |
| MAPE | Mean absolute percentage error | 0.0587 |
| SAE | Sum of the absolute errors | 69.4 |
Predictive Modules for Apellis Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Apellis Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Apellis Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Apellis Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Apellis Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Apellis Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Apellis Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Apellis Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Apellis Pharmaceuticals' historical news coverage. Apellis Pharmaceuticals' after-hype downside and upside margins for the prediction period are 16.39 and 27.11, respectively. We have considered Apellis Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Apellis Pharmaceuticals is not too volatile at this time. Analysis and calculation of next after-hype price of Apellis Pharmaceuticals is based on 3 months time horizon.
Apellis Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Apellis Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Apellis Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Apellis Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.35 | 5.36 | 0.00 | 0.01 | 5 Events / Month | 7 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
21.75 | 21.75 | 0.00 |
|
Apellis Pharmaceuticals Hype Timeline
Apellis Pharmaceuticals is presently traded for 21.75. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Apellis is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is presently at -0.35%. %. The volatility of related hype on Apellis Pharmaceuticals is about 19142.86%, with the expected price after the next announcement by competition of 21.74. About 14.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 5 days. Check out Historical Fundamental Analysis of Apellis Pharmaceuticals to cross-verify your projections.Apellis Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Apellis Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Apellis Pharmaceuticals' future price movements. Getting to know how Apellis Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Apellis Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CPRX | Catalyst Pharmaceuticals | (0.01) | 9 per month | 1.58 | 0.06 | 3.00 | (3.08) | 10.89 | |
| KNSA | Kiniksa Pharmaceuticals | (0.01) | 24 per month | 2.05 | 0.03 | 3.93 | (3.74) | 10.42 | |
| MLYS | Mineralys Therapeutics Common | (0.01) | 19 per month | 0.00 | (0.1) | 5.87 | (6.28) | 24.81 | |
| BEAM | Beam Therapeutics | 0.41 | 11 per month | 3.25 | 0.09 | 10.09 | (6.28) | 31.78 | |
| CDTX | Cidara Therapeutics | 0.14 | 13 per month | 1.30 | 0.13 | 5.93 | (4.54) | 105.72 | |
| ADPT | Adaptive Biotechnologies Corp | 0.06 | 10 per month | 3.86 | 0.02 | 9.94 | (5.19) | 29.55 | |
| SRRK | Scholar Rock Holding | (1.31) | 11 per month | 2.02 | 0.20 | 5.92 | (3.48) | 30.20 | |
| IDYA | Ideaya Biosciences | 0.03 | 10 per month | 2.08 | 0.06 | 4.86 | (3.78) | 15.68 | |
| AGIO | Agios Pharm | 0.31 | 10 per month | 0.00 | (0.04) | 5.99 | (3.94) | 56.88 | |
| RXRX | Recursion Pharmaceuticals | 0.11 | 10 per month | 0.00 | (0.12) | 7.59 | (6.85) | 17.21 |
Other Forecasting Options for Apellis Pharmaceuticals
For every potential investor in Apellis, whether a beginner or expert, Apellis Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Apellis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Apellis. Basic forecasting techniques help filter out the noise by identifying Apellis Pharmaceuticals' price trends.Apellis Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Apellis Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Apellis Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Apellis Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Apellis Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Apellis Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Apellis Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Apellis Pharmaceuticals stock market strength indicators, traders can identify Apellis Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 72050.57 | |||
| Daily Balance Of Power | (0.35) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 21.78 | |||
| Day Typical Price | 21.77 | |||
| Price Action Indicator | (0.16) | |||
| Period Momentum Indicator | (0.25) |
Apellis Pharmaceuticals Risk Indicators
The analysis of Apellis Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Apellis Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting apellis stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.01 | |||
| Standard Deviation | 5.25 | |||
| Variance | 27.56 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Apellis Pharmaceuticals
The number of cover stories for Apellis Pharmaceuticals depends on current market conditions and Apellis Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Apellis Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Apellis Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Apellis Pharmaceuticals Short Properties
Apellis Pharmaceuticals' future price predictability will typically decrease when Apellis Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Apellis Pharmaceuticals often depends not only on the future outlook of the potential Apellis Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Apellis Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 123.9 M | |
| Cash And Short Term Investments | 416.1 M |
Additional Tools for Apellis Stock Analysis
When running Apellis Pharmaceuticals' price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.